Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Th22 cells are essential for Tβ15-induced hair growth in mice.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

FoxN1 overexpression in young mice harms immune cell and skin development.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.